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Background: Patients are susceptible for knee osteoarthritis (KOA) with increasing age and obesity and KOA is
expected to become a major disabling disease in the future. An important feature of KOA on magnetic resonance
imaging (MRI) is changes in the subchondral bone, bone marrow lesions (BMLs), which are related to the future
degeneration of the knee joint as well as prevalent clinical symptoms. The aim of this study was to investigate the
changes in BMLs after a 16-week weight-loss period in obese subjects with KOA and relate changes in BMLs to the
effects of weight-loss on clinical symptoms.
Methods: This prospective cohort study included patients with a body mass index ≥ 30 kg/m2, an age ≥ 50 years and
primary KOA. Patients underwent a 16 weeks supervised diet program which included formula products and dietetic
counselling (ClinicalTrials.gov: NCT00655941). BMLs in tibia and femur were assessed on MRI before and after the
weight-loss using the Boston-Leeds Osteoarthritis Knee Score. Response to weight-loss in BML scores was dichotomised
to patients experiencing a decrease in BML scores (responders) and patients who did not (non-responders). The
association of BMLs to weight-loss was assessed by logistic regressions and correlation analyses.
Results: 39 patients (23%) were classified as responders in the sum of all BML size scores whereas 130 patients (77%)
deteriorated or remained stable and were categorized as non-responders. Logistic regression analyses revealed no
association between weight-loss < or ≥ 10% and response in BMLs in the most affected compartment (OR 1.86
[CI 0.66 to 5.26, p=0.24]). There was no association between weight-loss and response in maximum BML score
(OR 1.13 [CI 0.39 to 3.28, p=0.81]). The relationship between changes in BMLs and clinical symptoms revealed that an
equal proportion of patients classified as BML responders and non-responders experienced an OMERACT-OARSI
response (69 vs. 71%, p=0.86).
Conclusions: Weight-loss did not improve the sum of tibiofemoral BML size scores or the maximum tibiofemoral
BML score, suggesting that BMLs do not respond to a rapidly decreased body weight. The missing relationship
between clinical symptoms and BMLs calls for further investigation.
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The incidence of obesity has steadily increased over the
past decades and combined with the fact that patients
are susceptible for knee osteoarthritis (KOA) with in-
creasing age and obesity KOA is expected to become a
major disabling disease in the future [1-3]. It is highly
relevant to examine the effect of weight-loss in obese
KOA patients as this modifiable factor could have an ef-
fect on KOA-related structural changes, as assessed by
magnetic resonance imaging (MRI).
Clinical symptoms of KOA are increased in obese indi-
viduals and it is known that weight-loss can both im-
prove symptoms as well as decrease the risk of KOA
development [4-7]. A weight reduction of 10% and above
has been shown to significantly improve the KOA-
related symptoms regardless of the severity of structural
KOA changes as assessed by MRI [8-10].
At present, KOA is considered to be a whole organ dis-
ease that affects cartilage, bone marrow, ligaments, me-
nisci, joint capsule etc. and this can be assessed by MRI
scans using the BLOKS (Boston-Leeds Osteoarthritis
Knee Score) [11]. In general, an inconsistency exists be-
tween symptoms and imaging but specific MRI assessed
pathology has been shown to correlate to clinical symp-
toms and/or progression of disease [12-17]. A very im-
portant feature is changes in the subchondral bone
which may be evaluated by BLOKS as bone marrow le-
sions (BMLs). BMLs have been associated to the future
degeneration of the joint in KOA, prevalent clinical
symptoms and malalignment by means of an increased
mechanical load [13,18-21].
The aim of this study was to investigate the changes
in BMLs after a 16-week weight-loss intervention in
obese subjects with KOA and relate changes in BMLs
to the symptomatic effect of weight-loss. We hypothe-
sized that weight-loss would improve the overall and
maximum BML scores on MRI and that the effects of




192 participants were recruited November 2007–August
2008 from the outpatient clinic at the Department of
Rheumatology, Frederiksberg Hospital, Denmark, to take
part in the CAROT study (ClinicalTrials.gov identifier:
NCT00655941) [22]. Screening of possible participants
was performed by a formalized telephone interview. Of
the 388 screened subjects 187 patients were ineligible
and 9 patients declined to participate in the trial. 192 pa-
tients remained for inclusion to this prospective cohort
study; further details have been published [22].
To be eligible for inclusion, individuals had to be over
50 years of age, have a body mass index (BMI) ≥ 30 kg/m2,and show primary KOA diagnosed according to the
American College of Rheumatology (ACR) criteria com-
bining clinical symptoms as well as radiographic verifica-
tion of the diagnosis [23].
All patients signed and approved an informed consent.
At baseline and follow-up (week 16) we performed con-
ventional 1.5T MRI, whereas radiographs were only
obtained at baseline.
The study was approved by the local ethical committee
of The Capital Region of Denmark [H-B-2007-088] and
was carried out in accordance with the Helsinki Declar-
ation II and the European Guidelines for Good Clinical
Practise.
Interventions
The patients followed a supervised 16-week dietary pro-
gram consisting of nutritional education and a diet of
normal food plus meal replacements (The Cambridge
Diet, the Cambridge Health and Weight plan UK). The
details of the dietary program is described elsewhere
[22]. The dietary program consisted of an 8-weeks in-
tensive weight-loss phase with an all provided formula
diet. In the initial 8 weeks the patients were random-
ized to either Low Energy Diet (LED) or Very Low En-
ergy Diet (VLED), corresponding to 810 kcal/day or
485 kcal/day. This was followed by an 8-week period
with part formula/part conventional food.
MRI acquisition
MRI scans were obtained of the target knee (worst
symptomatic knee) using a high-field MRI (1.5 T) whole
body scanner (Philips Intera; software release 12.1.5.0)
following normal procedure taking one scan at each set-
ting. Patients were positioned supine and a send/receive
flex medium or large coil was fixed to the patient’s leg.
The study crew ensured that patients were scanned
using the same image and coil setup over time. The fol-
lowing five sequences were carried out:
Gradient echo-scout (10 mm slices, repetition time (TR)
12.3 ms, echo time (TE) 6.6 ms, 50° flip angle, field of view
(FOV) 300 x 300 mm, matrix 256 x 256). Sagittal 3D T1-
FFE gradient-echo (GRE) cartilage sequence (3 mm slices,
TR 21 ms, TE 8.4 ms, 20° flip angle, FOV 160 x 160 mm,
matrix 512 x 512). Sagittal multi-echo T2 weighted se-
quence (4 mm slices, TR 2531.3 ms, TE 100 ms, FOV
170 x 170 mm, matrix 256 x 256). Sagittal multi-echo
proton density (PD) weighted sequence (4 mm slices,
TR 2531.3 ms, TE 15.4 ms, FOV 170 x 170 mm, matrix
256 x 256). Coronal T1 spin echo (SE) sequence (3 mm
slices, TR 500 ms, TE 17 ms, FOV 150 x 150 mm,
matrix 512 x 512 ). Coronal STIR (short tau inversion
recovery) sequence 3 mm slices (TR 1797.9 ms, TE 55 ms,
FOV 150 x 150 mm, matrix 512 x 512). Scheduled time for
the overall MRI examination was 37 minutes.
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The imaging protocol used for the BLOKS assessment in
this study was the sagittal multi echo PD and T2
weighted scans, the STIR scan, the coronal SE T1 scan,
as well as a 3D reconstruction of the T1-FFE scan.
BMLs appear as ill-defined signal intensity changes in
the subchondral bone that are hypointense on T1w images
and hyperintense on STIR images [24]. BML assessments
were done semi-quantitatively in 7 of the 9 regions of the
knee, excluding the patellar regions. Analyses in this study
included data from 6 regions as we discarded the BML as-
sessments in the tibial intercondylar region. BMLs were
graded on a 0–3 scale based on the extent of regional in-
volvement; 0=none, 1=less than 10% of the region; 2=10%
to 25% of the region; 3= more than 25% of the region. Car-
tilage assessments were performed using the sagittal GRE
sequence which was transformed to a 3D multi planar
reconstructed (MPR) scan with near isotropic voxels
[25,26]. Osteophytes were evaluated using all three planes.
In the axial plane we scored lateral and medial osteophytes
on patella as well as anterior and posterior osteophytes on
femur using the axial reconstructed 3D gradient echo se-
quence. In the coronal plane we assessed central weight-
bearing osteophytes on tibia and femur. In the sagittal
plane we examined the anterior and posterior osteophytes
on femur and tibia, as well as the superior and inferior
osteophytes on patella [11]. For the evaluation of menisci
we analysed morphology, tears and extrusion on the cor-
onal T1w TSE (body) and on the sagittal T2w/PDw se-
quences (anterior and posterior horns).
Initial inter- and intra-reader analyses were performed
by HG and MB by scoring 20 consecutively selected
scans from the 187 completed baseline MRI examina-
tions. Selection was performed so that the analyses were
completed on 10 females and 10 males. The selected
patients displayed all levels of KOA joint damage, evalu-
ated by the medial compartment KL grade on radio-
graphs (2 patients having KL grade 0, 6 patients having
KL 1, 4 patients having KL 2, 6 patients having KL 3,
and 2 patients having KL 4). This procedure was similar
to what was done in the original BLOKS publication;
please see the online appendix [11]. Discrepancies in the
initial training period were resolved at meetings held by
MB and HG. Following this HG performed all the
BLOKS assessments.
All imaging assessments were performed using the
MacOS X based Osirix software (version 3.9.1) [27].
Radiographic assessments
Bi-plane weight-bearing semi-flexed radiographs were
taken of the index knee; one in the postero-anterior and
one in the lateral view (in case of bilateral symptoms we
used the most symptomatic knee). The radiographs were
obtained at inclusion by the same radiographers, using aPhilips Optimus apparatus and a standardized protocol
through all examinations.
MB analysed all radiographs using an atlas [28] and
performed a separate score for each knee compartment
according to the KL grading system [29]. As the original
grading by KL did not deal with the assessment of the
patellofemoral compartment we aimed to perform and
explore a whole joint radiographic assessment and thus
applied the KL criteria for tibiofemoral KOA to the
patellofemoral compartment [30]. The reported KL, for
the knee in general, was calculated as the maximum
score in either chamber.
Measurements of the tibiofemoral minimum joint
space width (mJSW) in the most affected tibiofemoral
compartment, judged by the KL grade, were performed
by HG. Inter- and intra-reader analyses of the mJSW
were performed by scoring the same scans as de-
scribed above for the inter- and intra-reader analyses
of BLOKS [10].
Knee joint alignment axis
Mechanical axis alignment was measured using a 6 cam-
era stereophotogrammetric system (Vicon MX, Vicon,
UK) with markers placed on anatomical landmarks (2nd
metatarsal head, lateral malleolus, posterior aspect of
calcaneus, lateral aspect of the leg, lateral femoral epi-
condyle, lateral aspect of the thigh, bilaterally on anter-
ior and posterior superior iliac spines) according to the
Plug-in-Gait biomechanical model, and anthropometric
measurements (height, leg length, and knee and ankle
diameters) to determine joint centres. The mechanical
axis alignment was defined as the frontal plane knee
joint angle expressed in the local joint coordinate sys-
tem. This procedure yields estimates of mechanical axis
alignment similar to full-limb weight-bearing radio-
graphs (R2=0.54) but without exposure to radiation [31].
A knee was defined as a varus when alignment was > 0º
and valgus when < 0º.
Isometric maximal voluntary contraction
Isometric maximal voluntary contraction (MVC) of
hamstrings and the quadriceps muscles were assessed
by isometric dynamometry at 60° (0° is full extension)
knee joint flexion angle (Biodex System 3 PRO, Biodex
Medical System, NY, USA) as described [32]. After cali-
brating the system, the subject was comfortably seated
and fastened to the dynamometer chair with leg- and
body-straps. Prior to the measurements, a correction
for gravity was made by registering the leg’s weight at
0° knee joint angle. The protocol was comprised of 6 suc-
cessive maximal efforts alternating between knee exten-
sion and knee flexion. Each contraction lasted 5 seconds
with a 10 second pause between contractions. After test
trials, performed to familiarize the patients to the test,
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MVC. Vigorous verbal encouragement was given in an
attempt to achieve maximal effort level. Isometric MVC-
values were normalized to body mass (Nm/kg).
Symptomatic assessments
Patient reported outcomes were examined at baseline
and after 16 weeks by assessing the OMERACT-OARSI
Responder Criteria and KOOS pain and function in daily
living (ADL), which were completed by the patients on a
validated touch screen solution [33].
The OMERACT-OARSI responder criterion was
assessed by average pain, disability and patient global
assessment of disease impact during the last week using
0 to 100 mm visual analogue scales (VAS) [34]. The
Knee Injury and Osteoarthritis Outcome Score (KOOS)
was used to assess impairment, disability and handicap
in 5 sub domains (function in daily living (ADL), pain,
knee-related quality of life, symptoms, and function in
sport/recreation). Items are scored from 0–4 and then
transformed into a 0–100 scale; 0 representing extreme
knee-related problems and 100 representing no knee-
related problems [35].
Statistical methods
Analyses were performed on available cases (per protocol
analysis). The most affected knee compartment was the
one with the worst status on radiographs and only this
single compartment for every patient case was included
in the analyses exploring the relationship between
weight-loss and BML responses. In order to examine the
importance of changes observed in BML gradings we
calculated the least significant criterion (LSC) using the
following formula LSC= 1.96 * SE * √ 2 * (1-r) (r; serial
correlation) [36]. To overcome that there can be several
BMLs in each region the BML scores were summed and
this overall score was considered for analyses together
with the maximum BML score.
We dichotomised the observed changes and our
dependent variable contained 0 for patients who
progressed or remained stable (non-responders) in their
BML scores and 1 for patients responding positively
(responders) [37]. As a sensitivity analysis we
performed ancillary statistical testing only including
patients with a BML score > 0 at baseline. Changes in
body weight was analysed as relative measures, being the
percentage change from baseline ((x16 - x0)/x0 * 100%).
Regarding the influence of weight-loss on BMLs we
conducted both regression and correlation analyses. A lo-
gistic regression model analysed the influence of a
weight-loss < or ≥ 10% of the initial body weight on the
response in BML scores. These regressions were repeated
with adjustments for age, gender and group allocation in
the underlying randomisation to either the LED or VLEDintervention. The correlation analyses examined the rela-
tionship between weight-loss, as a continuous variable,
and the response in BML scores. Changes in symptom-
atic outcomes (KOOS and OMERACT-OARI response)
were analysed as relative measures, being the percentage
change from baseline ((x16 - x0)/x0 * 100%), and were
then analysed in relation to the dichotomised response in
BML scores.
The inter- and intra-reader analyses of the mJSW were
performed by applying an ICC two-way mixed model
with measures of absolute agreement whereas the inter-
and intra-reader analyses of BLOKS were performed by
weighted kappa analyses based on individual scores.
A P-value less than 0.05 (two-tailed) or a 95% confi-
dence interval (CI) not including the null hypothesis was
regarded as statistically significant. All data analyses
were carried out applying SAS software (v. 9.2; SAS
Institute Inc., Cary, NC, USA).
Results
The study included 192 obese KOA patients and following
the 16 weeks of diet intervention 175 (%) patients
remained in the study. 187 (97%) MRI scans were com-
pleted at baseline, 172 (98%) MRI scans were obtained at
week 16 and this left the study with 169 (97%) patients
with complete MRI datasets. No statistical significant dif-
ferences were detected between baseline characteristics of
all the initially included patients (n=192) and the 169 pa-
tients included in the analyses in this paper (p<0.05).
The majority of patients were female (80%) and an
average participant had a BMI of 37.0 kg/m2 (SD 4.5)
and was 62.7 years (SD 6.3) of age (Table 1). One in
six patients did not have any BMLs at baseline. Radio-
graphic assessments showed that the majority of pa-
tients had a diminished joint space, compared to
normal patients, and 81% were classified as having KL
grade 1–3. Judged by radiographs 53 patients had
unicompartmental medial tibiofemoral KOA (defined
as a medial KL ≥ 2 and a lateral KL ≤ 1) whereas only
12 patients had solely lateral tibiofemoral KOA.
The inter- and intra-reader analyses of the subscores
in BLOKS revealed kappa values between 0.51-0.90
(Table 2) and the inter- and intra-reader analyses of
mJSW showed ICCs between 0.93 and 0.98, respectively.
The LSC for the total BML size score was < 0.5 and any
change in BML gradings was therefore considered to be
significant.
39 patients (23%) experienced a decrease in the sum
of all BML size scores (responders) and 130 patients
(77%) deteriorated in their score or remained stable
(non-responders) (Table 3).
Logistic regression analyses revealed no association be-
tween weight-loss category and response in BML size in
the most affected compartment (OR =1.95 [CI 0.70 to
Table 1 Baseline characteristics of all participants
Basic characteristics N = 169
Female no. (%) * 136 (80 %)
Age (years) * 62.7 ± 6.3 (49.6-76.5)
Height (cm) * 166 ± 8 (148–191)
Weight (kg) * 102.3 ± 14.6 (76.0-145.0)
BMI (kg/m2) * 37.0 ± 4.5 (30.1-51.6)
C-reactive protein (mg/L) 1 § 4.1 [2.2;7.3] (0.7-58.6)
Isometric maximal voluntary contraction
Quadriceps Muscle Strength (nm/kg) 1, 2 + 1.1 [0.9;1.4] (0.1-2.8)
Hamstrings Muscle Strength (nm/kg) 1, 2 + 0.5 [0.4;0.6] (0.0-1.1)
Radiographs
KL whole joint score (0–4)
1, 3 * 3.0 [2.0;3.0] (1.0 – 4.0)
KL medial tibiofemoral joint (0–4)
1, 3 * 2.0 [2.0;3.0] (0.0 – 4.0)
KL lateral tibiofemoral joint (0–4)
1, 3 * 2.0 [1.0;2.0] (0.0 – 4.0)
KL patellofemoral joint (0–4)
1, 3 * 2.0 [1.0;3.0] (0.0 – 4.0)
mJSW 1, 4 ^ 2.2 [0.00;3.8] (0.0 – 7.3)
MRI
Bone Marrow Lesions sum of size scores
1, 5 * 3.0 [1.0;5.0] (0.0-9.0)
Cartilage I combo score(0–81)
1, 6 * 15.0 [6.0;27.0] (0.0-61.0)
Osteophytes sum of scores (0–36)
1 * 13.0 [8.0;18.0] (1.0-35.0)
Menisci sum of extrusion scores (0–12)
1 * 7.0 [5.0;9.0] (0.0-12.0)
Menisci sum of morphology scores (0–38)
1 * 7.0 [6.0;8.0] (0.0-11.0)
Symptomatic assessment
KOOS Function in daily living (ADL)
* 60.4 ± 16.6 (11.8 – 98.5)
KOOS Pain
* 57.4 ± 15.9 (11.1 – 100)
Knee joint alignment axis 7
Varus (>0) / Valgus (<0) º 6.0 ± 4.8 (−8.6 – 23.7)
Plus-minus values are means ± SD and (min-max) unless otherwise stated.
1 Presented as median, interquartile range [Q1;Q3] and (min – max).
2 Measured isometric at 60 ° and normalized to body weight (nm/kg).
3 Scored using the Kellgren & Lawrence Grading system.
4 mJSW; minimum Joint Space Width (mm).
5 Sum of all BML size scores except those from patella.
6 For all analyzed areas we multiplied the “surface area”-score (0–3) with the
“full thickness”-score (0–3), reaching results between 0 and 9 for each area,
and then multiplied them into one “combo score” reaching a final score
between 0 and 81.
7 From the static anatomical landmark calibration trials for each subject the
knee joint mechanical axis alignment was calculated using a
Plug-In-Gait model.
Number of participants included in analysis varied due to missing data for specific
variables, as follows: * 169 patients; + 164 patients; ^ 152 patients; º 158 patients;
§ 162 patients.
Table 2 Weighted kappa and CI for inter- and intra-reader
reliability
Inter-reader1 Intra-reader1
Cartilage I 0.59 (0.31;0.87) 0.81 (0.71;0.91)
Cartilage II 0.71 (0.42;1.00) 0.75 (0.62;0.88)
Bone Marrow Lesions - -
Size score 0.65 (0.47;0.83) 0.66 (0.56;0.76)
Percentage BML score 0.72 (0.50;0.94) 0.76 (0.64;0.88)
Adjacency score 0.70 (0.48;0.92) 0.78 (0.66;0.90)
Osteophytes 0.71 (0.48;0.94) 0.81 (0.82;0.90)
Effusion 0.51 (0.21;0.81) 0.72 (0.61;0.83)
Synovitis (whole knee) 0.66 (0.42;0.90) 0.70 (0.60;0.80)
Synovitis (subscale) 0.61 (0.27;0.95) 0.58 (0.41;0.75)
Meniscal Extrusion 0.63 (0.38;0.88) 0.67 (0.55;0.79)
Meniscal Signal 0.80 (0.54;1.00) 0.80 (0.67;0.93)
Meniscal Tear 0.70 (0.38;1.00) 0.90 (0.80;1.00)
1 Validated on 20 patients consecutively selected according to protocol.
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mization group did not change the results significantly
(OR 1.86 [CI 0.66 to 5.26, p=0.24]). There were no as-
sociation between weight-loss during the diet interven-
tion period and the response in maximum BML score
(OR 1.13, CI 0.39 to 3.28, p=0.81). Focusing the ana-
lyses to only include patients having a baseline BML
score > 0 (N = 139) did not have any importantimpact on the results (Table 3). Analysing the associ-
ation between percentage weight-loss, as a continuous
variable, and changes in BMLs in the worst knee com-
partment did not show any relationship between the
two measures (Figure 1).
There were no differences in BML responses in the
underlying RCT (data not shown).
The relationship between changes in BMLs and clinical
symptoms revealed that an equal percentage of patients
classified as BML responders and non-responders experi-
enced an OMERACT-OARSI response (69 vs. 71%,
p=0.86). KOOS pain improved 23.9 and 22.6% for BML
responders and non-responders, respectively (mean differ-
ence 1.3 [95% CI −14.3 to 11.7], p=0.84) and similar re-
sults were found for KOOS ADL (25.6 and 25.7%, mean
difference 0.1 [95% CI −14.2 to 14.3], p=0.99). Compar-
able results were found when analysing the association
between response in maximum BMLs and KOOS pain
(16.3 and 24.2%, mean difference −7.9 [95% CI −6.8 to
22.6], p=0.29) as well as KOOS ADL (20.5 and 26.7%,
mean difference −6.2 [95% CI −10.0 to 22.3], p=0.45).
Discussion
In this study we aimed to assess whether or not a
16-week diet intervention program would impact on
BMLs, and we assessed both the maximum and overall
BML scores. Results from the study were that changes seen
in the total tibiofemoral sum of BML scores and maximum
BML scores were not impacted by weight loss. Also, we
found no relationship between improvements in clinical
symptoms and BMLs following a weight-loss.
BMLs are a common finding in painful osseous condi-
tions and have been proposed to consist of extracellular
Table 3 Changes in BMLs and clinical symptoms as a response to weight loss
Per protocol analyses Per protocol analyses
Patients with baseline BML score ≥ 0 Patients with baseline BML score > 0
N = 169 N = 139
Weight loss Weight loss Weight loss Weight loss
< 10 % ≥ 10 % < 10 % ≥ 10 %
Change in the sum of all BML scores
Responders N = 5 (15 %) N = 34 (25 %) N = 5 (20 %) N = 34 (30 %)
Non-responders N = 29 (85 %) N = 101 (75 %) N = 20 (80 %) N = 80 (70 %)
Change in the maximum BML score
Responders N = 5 (15 %) N = 23 (17 %) N = 5 (20 %) N = 23 (20 %)
Non-responders N = 29 (85 %) N = 112 (83 %) N = 20 (80 %) N = 91 (80 %)
OMERACT-OARSI response
Responders N = 16 (47 %) N = 103 (76 %) N = 13 (52 %) N = 87 (76 %)
Non-responders N = 18 (53 %) N = 32 (24 %) N = 12 (48 %) N = 27 (32 %)
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sure [38,39]. In cross sectional studies BMLs seem to be
the MRI feature most consistently associated to clinical
KOA symptoms [13,40,41], while only one longitudinal
study have shown this [20,42]. Furthermore, it has re-
peatedly been shown that BMLs predicts cartilage loss
and overall progression of disease [18,19].
Prior to the intervention our cohort had a high preva-
lence of BMLs, which is somewhat in contrast to previ-
ous reports investigating symptomatic KOA patients
[37,43]. In contrast to these trials Felson et al. revealed
results which are similar to those reported from this trial
[44]. Previous data have reported that BMLs fluctuate
over time. The development in total sum score of BML













































Figure 1 The relationship between weight-loss and changes in mediafrom the MOST study and other studies, while BMLs in
general developed more positive in our study population
when compared to data from other prospective observa-
tional cohorts [37,42,43,45]. The differences might be
due to the very rapid and successful weight-loss used in
our study, which was applicable with high intensity with
few adverse effects [22].
The present study did not provide any biological ex-
planation for the response in BMLs after weight-loss.
Data from the MOST study suggest an association be-
tween alignment of the knee and progression of BML
mediated through increased mechanical load in a
compartment-specific manner, since alignment is be-
lieved to influence load distribution [21]. The present re-
sults contrast this, because the changes in BMLs weret loss (%) 
R2=0.00, p=0.96
l tibiofemoral BML size scores.
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Although the present study was not focused on align-
ment, it indicates that the suggested association between
alignment and BML progression [21] is not mediated
through mechanical loadings (Table 3). Existing litera-
ture suggests that obesity related inflammatory mecha-
nisms and biomechanical malfunction are both related
to structural damage in the knee, but even so, the
aetiopathogenesis of BMLs is still not fully understood
[46-48]. Lacking the complete overview of mechanisms
related to KOA might explain the absent capacity of this
study to show an effect of weight loss on BMLs.
Neither did the study provide data clarifying the rela-
tionship between BML changes and the effects of
weight-loss on clinical symptoms. Several factors are
likely to have an impact on the assessments and inter-
pretations of clinical symptoms in KOA. First of all, lon-
gitudinal changes in BMLs have not been shown to
correlate with corresponding changes in KOA symptoms
[42]. Secondly, as patients are subjected to KOA symp-
toms over a long period of time, the patients may de-
velop peripheral joint sensitization as well as plasticity
changes in the central nervous system [49,50] that could
disturb the relationship between structural damage and
symptoms [46]. Thirdly, the overall levels of cytokines
and adipokines have an impact on clinical symptoms.
Last but not least, the subjective experience of pain is
influenced by cognitive, social, emotional and behav-
ioural factors; e.g. expectations, general anxiety, and pre-
vious experience [51,52]. All of these considerations are
likely to influence the clinical observations and could ex-
plain the lack of association between changes in symp-
toms and MRI-graded pathology.
The inter- and intra-reader analyses of both the
BLOKS assessments and the mJSW showed results that
were comparable to those achieved by others [11,53,54].
The study has some limitations. The agreement on
when an observed change is important is not yet clarified
for BMLs assessed by BLOKS, but we believe that our es-
timate of the LSC validated our results. Our analyses are
based on single determinations of MRI items which may
result in erroneous estimations of associations due to the
subjective variability of these. The MRI protocol for this
study did not include all the recommended sequences for
optimal gradings of KOA pathology. However, we believe
that the BLOKS assessment performed in general served
the question addressed in this study. The protocol only
included coronal slices for the assessment of BMLs in
trochlea and the dorsal portion of the femoral condyles
and even though we consider this to be reasonable
[55,56] it is likely not to be optimal. In general, we con-
sider the coronal STIR and T1w sequences adequate for
a reasonable assessment of BMLs in the tibial and fem-
oral bones as Osirix allowed for a localization of thescored lesions by using sagittal sequences obtained for
other purposes. However, we recognize the limitations
this strategy withholds in terms of correctly assessing
BMLs located at the margins of our slices. Due to un-
acceptable coverage of patella, data did not include BML
scores from this part of the knee joint. Also, we chose to
sum the scores of individual assessments of cartilage
pathology, BMLs and menisci to form a sum-score for
each of the three compartments and to exclude scores
from the tibial intercondylar region [57-59]. With respect
to the KL gradings a limitation is that we did not perform
intra observer variation of the KL grading. Finally,
changes assessed over period of just 16 weeks may be too
short a time frame for assessing changes in BMLs, even
though preliminary data support that this may in fact
occur [44].
Conclusions
Weight-loss did not improve the total sum of tibio-
femoral BML size scores or the maximum BML score,
suggesting that BMLs do not respond to a rapidly de-
creased body weight. Ancillary sensitivity testing that ex-
cluded patients with no BMLs at baseline showed similar
results and thus supported the initial findings.
In conclusion, this study did not show any association
between weight-loss and response in BML scores and
failed to connect a positive BML response to clinical im-
provements. The missing relationship between changes in
clinical symptoms and BMLs calls for further investigation.
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